The Immunology Applications Core Facility (IACF) was created in 1998 by combining three of the existing UCCRC core facilities - the Flow Cytometry, Immunohistochemistry and Fitch Monoclonal Antibody facilities. These facilities serve the faculty by providing access to state-of-the-art immunological technologies and quantitative analytical approaches to measure molecular, cellular and tissue function. These facilities, which are utilized by Cancer Center researchers in many areas of study, serve basic research in cellular structure/function as well as translational research in clinical applications and molecular medicine. The Flow Cytometry Facility provides analytical detection and sorting of single cell suspensions and sub cellular components using multiparameter fluorescence technology. Services include training on use of benchtop flow cytometers, cell sorting using high speed, conventional speed and magnetic bead technologies. The Immunohistochemisty Facility provides cellular detection within the context of the surrounding tissue. The services include tissue sectioning, H&E staining, Immunostaining and in situ hybridization using both manual and automated staining technologies. The Fitch Monoclonal Antibody Facility provides the antibodies necessary for the detection of cells and subcellular components. The services provided include novel antibody production (immunizations and splenic fusion to myeloma cells), large scale antibody production using hollow fiber bioreactor systems and antibody purification. The facilities expanded into newly renovated space in February, 2001. This allows the facilities to continue to grow to meet the research demands of the UCCRC faculty.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-28
Application #
6592115
Study Section
Project Start
2002-05-15
Project End
2007-03-31
Budget Start
Budget End
Support Year
28
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications